Literature DB >> 12855686

1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells.

Delphine Delacour1, Valérie Gouyer, Emmanuelle Leteurtre, Tounsia Ait-Slimane, Hervé Drobecq, Christelle Lenoir, Odile Moreau-Hannedouche, Germain Trugnan, Guillemette Huet.   

Abstract

In previous work we reported that long term treatment of polarized HT-29 cells by 1-benzyl-2-acetamido-2-deoxy-alpha-d-galactopyranoside (GalNAcalpha-O-bn) induced undersialylation and intracellular distribution of apical glycoproteins such as dipeptidyl peptidase IV (DPP-IV), and we suggested therefore that sialylation could act as an apical targeting signal. In this work, the apical direct biosynthetic route was studied after transfection of polarized enterocyte-like HT-29 5M12 cloned cells with a murine cDNA coding for a soluble form of DPP-IV, which was secreted into the apical medium. A 24-h treatment of transfected cells by GalNAcalpha-O-bn markedly inhibited the apical secretion and the sialylation of this soluble murine DPP-IV, which became blocked inside the cell. A similar short GalNAcalpha-O-bn treatment also induced an intracellular distribution of both endogenous transmembrane DPP-IV and proteins involved in the regulation of the apical trafficking such as the apical t-SNARE syntaxin-3 and the raft-associated protein annexin XIIIb, whereas the basolateral t-SNARE syntaxin-4 kept its normal localization. These apical membrane proteins moved efficiently from trans-Golgi network to apical carrier vesicles but failed to be transported from carrier vesicles to the apical plasma membrane. Isolation of membrane microdomains showed that GalNAcalpha-O-bn induced the formation of abnormal lipid-rich microdomains in comparison to normal rafts, as shown by their lower buoyant density and their depletion in annexin XIIIb. In conclusion, GalNAcalpha-O-bn blocks the anterograde traffic to the apical surface of polarized HT-29 cells at the transport level or docking/fusion level of carrier vesicles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855686     DOI: 10.1074/jbc.M305755200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.

Authors:  Carol L Kinlough; Paul A Poland; Sandra J Gendler; Polly E Mattila; Di Mo; Ora A Weisz; Rebecca P Hughey
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

3.  Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.

Authors:  Huan-Li Xu; Xin Zhao; Ke-Ming Zhang; Wei Tang; Norihiro Kokudo
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Evidence for core 2 to core 1 O-glycan remodeling during the recycling of MUC1.

Authors:  Hanieh Razawi; Carol L Kinlough; Simon Staubach; Paul A Poland; Youssef Rbaibi; Ora A Weisz; Rebecca P Hughey; Franz-Georg Hanisch
Journal:  Glycobiology       Date:  2013-05-01       Impact factor: 4.313

5.  Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells.

Authors:  Delphine Delacour; Valérie Gouyer; Jean-Pierre Zanetta; Hervé Drobecq; Emmanuelle Leteurtre; Georges Grard; Odile Moreau-Hannedouche; Emmanuel Maes; Alexandre Pons; Sabine André; André Le Bivic; Hans Joachim Gabius; Aki Manninen; Kai Simons; Guillemette Huet
Journal:  J Cell Biol       Date:  2005-05-09       Impact factor: 10.539

Review 6.  Altered Mucins (MUC) trafficking in benign and malignant conditions.

Authors:  Suhasini Joshi; Sushil Kumar; Amit Choudhury; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Oncotarget       Date:  2014-09-15

7.  Sialylation of N-linked glycans mediates apical delivery of endolyn in MDCK cells via a galectin-9-dependent mechanism.

Authors:  Di Mo; Simone A Costa; Gudrun Ihrke; Robert T Youker; Nuria Pastor-Soler; Rebecca P Hughey; Ora A Weisz
Journal:  Mol Biol Cell       Date:  2012-08-01       Impact factor: 4.138

8.  Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro.

Authors:  Alex Olvera; Javier P Martinez; Maria Casadellà; Anuska Llano; Míriam Rosás; Beatriz Mothe; Marta Ruiz-Riol; Gemma Arsequell; Gregorio Valencia; Marc Noguera-Julian; Roger Paredes; Andreas Meyerhans; Christian Brander
Journal:  Front Immunol       Date:  2018-01-26       Impact factor: 7.561

Review 9.  Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.

Authors:  Erin E Mulvihill; Daniel J Drucker
Journal:  Endocr Rev       Date:  2014-09-12       Impact factor: 19.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.